how long do you stay on glp-1 Medications in Your System? how long should i stay

Key Takeaways: Rapid adoption is driving better access, but irrational, unsupervised use is raising red flags

General Safety Profile Based on the preclinical dataset and the limited human exposure data: No prominent signal of hepatic, renal, or hematological toxicity at tested doses No prominent cardiovascular safety flag Pregnancy and lactation as with most research compounds, safety not established Long-term effects not characterized What Clinicians Should Actually Tell Patients For patients asking about 5-amino-1MQ, a reasonable response framework: What the compound is: A research-stage small molecule inhibiting NNMT with promising preclinical fat loss data

According to the National Institute of Diabetes and Digestive and Kidney Diseases, adults who are overweight or obese should lose 5% to 10% of their body weight within 6 months for weight loss success and better outcomes (12)

The PREDIMED data is instructive: participants consuming substantial amounts of EVOO in an unrestricted-calorie context did not gain weight -- and showed slight improvements in central adiposity -- over nearly five years